FCF Yield

The current FCF Yield of 9.1% means that for every dollar you invest in Teladoc stock, the company generates about 9.1 cents in free cash flow per year — free cash flow is the cash left after operating and capital expenses, and the yield compares that cash to the stock price.

This yield ranks in the 91st percentile among healthcare sector peers, well above the sector median of 3.6%, indicating the stock offers a much higher cash return relative to its price than most competitors. The year-over-year change is not available, but quarter-over-quarter the metric fell by 60.6%, dropping from 23.1% to 9.1%. While the current high level suggests the stock is cheap on a cash-flow basis, the sharp quarterly decline signals that free cash flow dropped or the price rose quickly, introducing uncertainty about the sustainability of that cash generation. This combination — a strong yield level paired with a steep recent decline — points to a potential value opportunity alongside elevated risk of further deterioration. The metric supports the overall NEUTRAL verdict because the high yield is attractive, but the negative trend tempers enthusiasm, justifying a hold rather than a buy or sell.

Frequently Asked Questions

Closest Sector Peers